27 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

NOVN

Novartis
CHF86.130.4%-0.7%CHF188.6bCHF97.68PE24.1xE9.1%3.8%

ROG

Roche Holding
CHF224.40-0.9%-18.5%CHF180.6bCHF281.28PE15.6xE8.3%4.3%

SAN

Sanofi
€88.12-1.0%-13.5%€110.0b€107.29PE20.4xE14.0%4.3%

ZTS

Zoetis
US$163.200.1%-4.8%US$76.5bUS$220.68PE31.9xE8.1%1.1%

MRK

Merck KGaA
€150.30-4.6%-6.4%€65.3b€180.75PE23.1xE9.9%1.5%

4507

Shionogi
JP¥7,339.00-2.8%21.4%JP¥2.1tJP¥7,713.08PE13.5xE-0.6%2.0%

IPN

Ipsen
€108.901.6%2.9%€9.0b€125.03PE14.6xE5.9%1.1%

4151

Kyowa Kirin
JP¥2,607.00-0.8%-12.1%JP¥1.4tJP¥3,066.67PE17.2xE3.8%2.2%

600085

Beijing Tongrentang
CN¥41.911.6%-23.6%CN¥57.5bCN¥54.90PE34.4xE14.6%1.2%

4528

Ono Pharmaceutical
JP¥2,437.00-1.2%-11.3%JP¥1.1tJP¥2,672.50PE9xE-6.9%3.3%

999

China Resources Sanjiu Medical & Pharmaceutical
CN¥53.064.4%-6.2%CN¥52.4bCN¥65.75PE18.4xE13.3%2.8%

2001

Zhejiang NHU
CN¥16.50-3.3%-7.9%CN¥50.7bCN¥19.22PE18.7xE23.2%3.0%

661

Changchun High-Tech Industries (Group)
CN¥118.08-3.9%-28.7%CN¥47.5bCN¥203.00PE10.5xE12.2%3.8%

2422

Sichuan Kelun Pharmaceutical
CN¥29.00-3.4%-1.8%CN¥46.1bCN¥39.72PE20.4xE11.4%2.1%

2603

Shijiazhuang Yiling Pharmaceutical
CN¥20.02-1.2%-34.7%CN¥33.4bCN¥27.02PE12.4xE6.8%2.5%

KRKG

Krka d. d
€124.50-2.4%14.2%€3.8b€133.64PE12.2xE4.3%5.3%

513

Livzon Pharmaceutical Group
CN¥36.50-2.1%-3.1%CN¥29.6bCN¥41.05PE17.2xE10.2%3.7%

600535

Tasly Pharmaceutical Group
CN¥15.69-3.3%1.1%CN¥23.3bCN¥14.92PE20.8xE12.2%2.1%

2262

Jiangsu Nhwa Pharmaceutical
CN¥22.55-1.2%-14.2%CN¥22.7bCN¥31.49PE21.9xE18.9%1.4%

600867

Tonghua Dongbao Pharmaceutical
CN¥10.19-3.7%-15.7%CN¥20.2bCN¥15.27PE17.3xE11.5%2.5%

500674

Sanofi India
₹8,447.70-2.3%42.2%₹194.6b₹9,497.60PE32.3xE9.5%2.0%

867

China Medical System Holdings
HK$7.40-1.3%-44.9%HK$18.1bHK$13.70PE7xE8.9%5.7%

603456

Zhejiang Jiuzhou Pharmaceutical
CN¥16.43-8.5%-52.1%CN¥14.8bCN¥32.14PE14.3xE19.8%2.4%

4516

Nippon Shinyaku
JP¥4,334.000.4%-26.0%JP¥291.9bJP¥6,371.43PE12.1xE4.9%2.9%
Page 1 of 2
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.